Short-Term Effect of SARS-CoV-2 Spike Protein Receptor-Binding Domain-Specific Antibody Induction on Neutrophil-Mediated Immune Response in Mice
Vaccination protects against COVID-19 via the spike protein receptor-binding domain (RBD)-specific antibody formation, but it also affects the innate immunity. In the present study, the team of scientists from the Laboratory of cell interactions IBCh RAS in collaboration with the colleagues from MIPT demonstrated that RBD-coated 100 nm particles induced neutrophil activation after the application to the airways of mice with in advance induced RBD-specific antibodies. In these mice, the portion of mature neutrophils was elevated in the circulating neutrophil population. These neutrophils demonstrated decreased ability of neutrophil extracellular traps (NETs) formation compared to the neutrophils from control mice. Thus, the induction of RBD-specific antibodies stimulates the activation of mature neutrophils that react to RBD-coated particles without triggering excessive inflammation. The study was supported RFBR 20-04-60311 and published in the International Journal of Molecular Sciences.
august 2, 2022